Verve Therapeutics Inc. (VERV)
undefined
undefined%
At close: undefined
5.81
1.57%
After-hours Dec 13, 2024, 06:09 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 11.76M 1.94M - - -
Cost of Revenue 5.46M 6.71M 3.38M 1.33M 106.00K
Gross Profit 6.30M -4.77M -3.38M -1.33M -106.00K
Operating Income -223.12M -165.69M -87.07M -40.63M -13.64M
Interest Income - 6.87M 142.00K 162.00K 278.00K
Pretax Income -199.79M -157.33M -120.31M -45.70M -19.30M
Net Income -200.07M -157.39M -118.64M -45.54M -19.02M
Selling & General & Admin 49.94M 37.53M 18.86M 5.26M 2.50M
Research & Development 184.95M 130.09M 68.20M 35.37M 11.14M
Other Expenses - 1.49M -33.39M -5.24M -5.93M
Operating Expenses 234.88M 167.63M 87.07M 40.63M 13.64M
Interest Expense - - - - -
Selling & Marketing Expenses - - - - -
Cost & Expenses 234.88M 167.63M 87.07M 40.63M 13.64M
Income Tax 275.00K 53.00K -1.68M -162.00K -278.00K
Shares Outstanding (Basic) 64.18M 54.02M 48.51M 48.22M 48.22M
Shares Outstanding (Diluted) 64.18M 54.02M 48.51M 48.22M 48.22M
EPS (Basic) -3.12 -2.91 -2.45 -0.94 -0.39
EPS (Diluted) -3.12 -2.91 -2.45 -0.94 -0.39
EBITDA -217.67M -162.88M -85.53M -39.30M -13.54M
Depreciation & Amortization 5.46M 6.71M 3.38M 1.33M 106.00K